Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model

Gender Medicine

Volumn 6, Issue 1, 2009, Pages 300-311

  Walf, Alicia A ^a   Frye, Cheryl A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

anxiety; breast cancer; depression; estrogen; menopause

Indexed keywords

ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; BREAST CARCINOGENESIS; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS; LIGHT DARK CYCLE; LOCOMOTION; LORDOSIS; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; UTERUS WEIGHT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; EXERCISE TEST; FEMALE; NEOPLASMS; ORGAN SIZE; POSTMENOPAUSE; RATS; TUMOR BURDEN; UTERUS;

EID: 65649127145     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2009.04.004     Document Type: Article

References (65)

1. Miniño A.M., Heron M.P., Murphy S.L., et al., the Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Deaths: Final data for 2004. Natl Vital Stat Rep 55 (2007) 1-119
2. Henriques A., and Dickson N. Menopause: The Woman's View. 2nd rev ed. (1992), Quartet Books Ltd, London, United Kingdom
3. Rapp P.R., Morrison J.H., and Roberts J.A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23 (2003) 5708-5714
4. Rossouw J.E., Anderson G.L., Prentice R.L., et al., the Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
5. Sherwin B.B. The critical period hypothesis: Can it explain discrepancies in the oestrogen-cognition literature?. J Neuroendocrinol 19 (2007) 77-81
6. Shumaker S.A., Legault C., Rapp S.R., et al., the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 289 (2003) 2651-2662
7. Clemons M., and Goss P. Estrogen and the risk of breast cancer [published correction appears in N Engl J Med. 2001;344:1804]. N Engl J Med 344 (2001) 276-285
8. Hulka B.S. Epidemiology of susceptibility to breast cancer. Prog Clin Biol Res 395 (1996) 159-174
9. Lambe M., Hsieh C.C., Chan H.W., et al. Parity, age at first and last birth, and risk of breast cancer: A population-based study in Sweden. Breast Cancer Res Treat 38 (1996) 305-311
10. Madigan M.P., Ziegler R.G., Benichou J., et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87 (1995) 1681-1685
11. Ramon J.M., Escriba J.M., Casas I., et al. Age at first full-term pregnancy, lactation and parity and risk of breast cancer: A case-control study in Spain. Eur J Epidemiol 12 (1996) 449-453
12. Thomas H.V., Key T.J., Allen D.S., et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 76 (1997) 401-405
13. Cauley J.A., Lucas F.L., Kuller L.H., et al., the Study of Osteoporotic Fractures Research Group. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann Intern Med 130 (1999) 270-277
14. Hankinson S.E., Willett W.C., Manson J.E., et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90 (1998) 1292-1299
15. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87 (1995) 190-197
16. Meijer W.J., and van Lindert A.C. Prophylactic oophorectomy. Eur J Obstet Gynecol Reprod Biol 47 (1992) 59-65
17. Schairer C., Persson I., Falkeborn M., et al. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70 (1997) 150-154
18. Colditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 (1995) 1589-1593
19. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer [published correction appears in Lancet. 1997;350:1484]. Lancet 350 (1997) 1047-1059
20. Magnusson C., Baron J.A., Correia N., et al. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81 (1999) 339-344
21. Seeman M.V. Psychopathology in women and men: Focus on female hormones. Am J Psychiatry 154 (1997) 1641-1647
22. Harsh V., Schmidt P.J., and Rubinow D.R. The menopause transition: The next neuroendocrine frontier. Expert Rev Neurother 7 Suppl 11 (2007) S7-S10
23. Bloch M., Daly R.C., and Rubinow D.R. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 44 (2003) 234-246
24. Rubinow D.R., and Schmidt P.J. Gonadal steroid regulation of mood: The lessons of premenstrual syndrome. Front Neuroendocrinol 27 (2006) 210-216
25. Bebbington P., Hurry J., Tennant C., et al. Epidemiology of mental disorders in Camberwell. Psychol Med 11 (1981) 561-579
26. Jenkins R. Sex differences in depression. Br J Hosp Med 38 (1987) 485-486
27. Weissman M.M., and Klerman G.L. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34 (1977) 98-111
28. Wittchen H.U., and Hoyer J. Generalized anxiety disorder: Nature and course. J Clin Psychiatry 62 Suppl 11 (2001) 15-19 discussion 20-21
29. Schmidt P.J., Nieman L., Danaceau M.A., et al. Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol 183 (2000) 414-420
30. Almeida O.P., Lautenschlager N., Vasikaram S., et al. Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. Am J Geriatr Psychiatry 13 (2005) 142-149
31. Cohen L.S., Soares C.N., Poitras J.R., et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: A preliminary report. Am J Psychiatry 160 (2003) 1519-1522
32. Ditkoff E.C., Crary W.G., Cristo M., and Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78 (1991) 991-995
33. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72 (1991) 336-343
34. Walf A.A., and Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31 (2006) 1097-1111
35. Vesco K.K., Haney E.M., Humphrey L., et al. Influence of menopause on mood: A systematic review of cohort studies. Climacteric 10 (2007) 448-465
36. Voytko M.L., and Tinkler G.P. Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause. Front Biosci 9 (2004) 1899-1914
37. Walf A.A., and Frye C.A. Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen. Steroids 73 (2008) 997-1007
38. Walf A.A., and Frye C.A. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30 (2005) 1288-1301
39. Nomikos G.G., and Spyraki C. Influence of oestrogen on spontaneous and diazepam-induced exploration of rats in an elevated plus maze. Neuropharmacology 27 (1988) 691-696
40. Slater J., and Blizard D.A. A reevaluation of the relation between estrogen and emotionality in female rats. J Comp Physiol Psychol 90 (1976) 755-764
41. Guide for the Care and Use of Laboratory Animals. Reports, DRR/National Institutes of Health (1985), Offices of Science and Health, Bethesda, Md DHEW Publication 80-23
42. Walf AA, Frye CA. Estradiol enhances sociosexual behavior and augments carcinogen-induced tum-origenesis in ovariectomized rats. Age. In press.
43. Frye C.A., Bayon L.E., Pursnani N.K., and Purdy R.H. The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res 808 (1998) 72-83
44. Walf A.A., and Frye C.A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 30 (2005) 1598-1609
45. Hardy D.F., and Debold J.F. Effects of mounts without intromission upon the behavior of female rats during the onset of estrogen-induced heat. Physiol Behav 7 (1971) 643-645
46. Frye C.A., Petralia S.M., and Rhodes M.E. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav 67 (2000) 587-596
47. Frye C.A., and Bayon L.E. Mating stimuli influence endogenous variations in the neurosteroids 3alpha, 5alpha-THP and 3alpha-Diol. J Neuroendocrinol 11 (1999) 839-847
48. Rodbard D., and Hutt D.M. Statistical analysis of radio-immunoassay and immunoradiometric assays: A generalized, weighted iterative, least squares method for logistic curve fitting. In: International Atomic Energy Agency (Ed). Symposium on Radioimmunoassay and Related Procedures in Medicine (1974), Uniput, New York, NY 209-233
49. Frye C.A., and Walf A.A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41 (2002) 306-315
50. Leung G., Tsao S.W., and Wong Y.C. Sex hormone-induced mammary carcinogenesis in female Noble rats: Detection of differentially expressed genes. Breast Cancer Res Treat 77 (2003) 49-63
51. Cheung S.Y., Yuen M.T., Choi H.L., et al. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats. Int J Oncol 22 (2003) 1383-1395
52. Russo I.H., Koszalka M., Gimotty P.A., and Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 62 (1990) 243-247
53. Russo J., and Russo I.H. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39 (1996) 7-20
54. Stewart S.L., Querec T.D., Ochman A.R., et al. Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res 64 (2004) 8177-8183
55. Razavi D., Farvacques C., Delvaux N., et al. Psychosocial correlates of oestrogen and progesterone receptors in breast cancer. Lancet 335 (1990) 931-933
56. Osterlund M.K., Witt M.R., and Gustafsson J.A. Estrogen action in mood and neurodegenerative disorders: Estrogenic compounds with selective properties - the next generation of therapeutics. Endocrine 28 (2005) 235-242
57. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci 24 (2003) 479-485
58. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388 (1997) 507-525
59. Imwalle D.B., Gustafsson J.A., and Rissman E.F. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav 84 (2005) 157-163
60. Krezel W., Dupont S., Krust A., et al. Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc Natl Acad Sci U S A 98 (2001) 12278-12282
61. Rocha B.A., Fleischer R., Schaeffer J.M., et al. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 179 (2005) 637-643
62. Walf A.A., Ciriza I., Garcia-Segura L.M., and Frye C.A. Antisense oligodeoxynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology 33 (2008) 431-440
63. Mazzucco C.A., Walker H.A., Pawluski J.L., et al. ERalpha, but not ERbeta, mediates the expression of sexual behavior in the female rat. Behav Brain Res 191 (2008) 111-117
64. Galea L.A. Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res Rev 57 (2008) 332-341
65. Wallace M., Luine V., Arellanos A., and Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res 1126 (2006) 176-182